Adial Pharmaceuticals News

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Moomoo NewsNov 15, 2024 16:32 ET

Adial Pharmaceuticals Analyst Ratings

BenzingaNov 14, 2024 06:53 ET

Adial Pharmaceuticals Initiated With a Buy at Rodman & Renshaw

TipRanksNov 14, 2024 06:51 ET

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Moomoo NewsSep 20, 2024 12:32 ET

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Moomoo NewsAug 15, 2024 14:32 ET

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Moomoo NewsJul 25, 2024 08:56 ET

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Moomoo NewsJul 24, 2024 16:52 ET

Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)

TipRanksApr 11, 2024 11:35 ET

Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target

BenzingaJul 12, 2023 05:59 ET

ADial Pharmaceuticals Cut to Hold From Buy by Maxim Group

Dow JonesAug 17, 2022 08:15 ET

Adial Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsAug 17, 2022 08:06 ET

Maxim Group Adjusts Adial Pharmaceuticals Price Target to $3 From $5, Maintains Buy Rating

MT NewswiresJul 21, 2022 12:59 ET

Brookline Capital Markets Keeps Their Buy Rating on Adial Pharmaceuticals (ADIL)

TipRanksJul 20, 2022 16:10 ET

Adial Pharmaceuticals (ADIL) Receives a Buy from Maxim Group

TipRanksJun 28, 2022 14:13 ET